Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A new classification system may more accurately reflect liver-related death trends in the United States.
The first meta-analysis to examine hep C treatment outcomes in seniors versus non-seniors found that cure rates are comparable.
A recent study tested the effectiveness and tolerability of Technivie (ombitasvir/paritaprevir/ritonavir) among those over 65.
A pooled analysis of numerous studies found the safety and efficacy of the regimen was comparable between those under and those over 65.
The deal resolves one of many lawsuits against a Minot facility and its lab services provider for allegedly infecting 52 seniors in 2013.
Researchers are warning about an increased risk of severe liver injury among senior citizens using the broad-specturm fluoroquinolone antibiot...
The need to provide and coordinate care for elderly people living with liver cirrhosis is expected to increase in the coming years.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.